Filter
1250
Filtered Results: 1250
Text search:
Center
for
Disease
Control
and
Prevention
(CDC)
Featured
Recommendations
118
New Publications
317
Language
Document type
No document type
732
Guidelines
183
Studies & Reports
154
Manuals
69
Fact sheets
40
Strategic & Response Plan
32
Training Material
21
Situation Updates
8
Infographics
5
Resource Platforms
4
Brochures
1
Videos
1
Countries / Regions
Global
48
Africa
40
Liberia
38
Ethiopia
38
Sierra Leone
35
India
35
Kenya
31
Rwanda
29
Latin America and the Carribbean
21
Nigeria
20
Tanzania
20
Mozambique
16
Senegal
15
Ghana
15
Uganda
15
Bangladesh
15
Guinea
14
Nepal
14
Zambia
14
Malawi
14
Haiti
13
Cambodia
13
Western and Central Europe
13
Congo, Democratic Republic of
12
USA
12
Brazil
12
Russia
12
Asia
11
West and Central Africa
10
Philippines
9
South Africa
9
Burkina Faso
8
Zimbabwe
8
Indonesia
8
Namibia
8
Ukraine
8
Eastern Europe
8
Angola
7
East and Southern Africa
7
Germany
6
Colombia
6
South Sudan
5
Ecuador
5
Middle East and North Africa
5
Vietnam
5
Madagascar
4
Lesotho
4
Guinea-Bissau
3
Cameroon
3
Syria
3
Thailand
3
Myanmar / Burma
3
South–East Asia Region
3
France
3
Portugal
3
Spain
3
Côte d’Ivoire / Ivory Coast
2
Niger
2
Pakistan
2
China
2
Eswatini/ Swaziland
2
Botswana
2
Bolivia
2
Chile
2
Yemen
2
Eastern Europe and Central Asia
2
Venezuela
2
Laos
2
Mali
1
Somalia
1
Afghanistan
1
Turkey
1
Malaysia
1
Benin
1
Peru
1
Burundi
1
Honduras
1
Mexico
1
Sri Lanka
1
Paraguay
1
Bhutan
1
Albania
1
Armenia
1
Southern Africa
1
Timor Leste/ East Timor
1
Tajikistan
1
Qatar
1
Kazakhstan
1
North America
1
Japan
1
Mauritius
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
437
Clinical Guidelines
115
Public Health
60
Key Resources
55
Women & Child Health
51
Capacity Building
25
Pharmacy & Technologies
24
Toolboxes
COVID-19
148
HIV
123
TB
101
Ebola
78
AMR
74
Rapid Response
61
Mental Health
38
NTDs
37
Zika
34
Planetary Health
27
Caregiver
24
NCDs
22
Cholera
20
Natural Hazards
16
Pharmacy
16
Refugee
13
Specific Hazards
13
Disability
10
Polio
9
Global Health Education
9
Health Financing Toolbox
7
Conflict
3
Social Ethics
1
Website last accessed in 12.03.23
CDC’s Lauren Greenberg writes about building rabies diagnostic capacity in the effort to control rabies in countries that are most affected by the ....
The term leishmaniasis encompasses multiple clinical syndromes, including the cutaneous, mucosal, and visceral forms, which result from infection of macrophages in the dermis, in the naso-orpharyngeal mucosa, ... throughout the reticuloendothelial system, respectively. The infection can range from asymptomatic to severe in all of these forms. Cutaneous and mucosal leishmaniasis can cause severe morbidity; visceral and mucosal leishmaniasis can be life threatening.
96 million American adults - more than 1 - 3 - have prediabetes
If you’re interested in preventing type 2 diabetes, this guide can help you get started. Congratulations on taking the first step! By reading this, you’re already on your way. Prediabetes puts you on the road to possibly getting type 2 diabetes. Find out now, in less than 1 minute, if you may ha...
If your result shows you’re at high risk for type 2 diabetes, talk to your doctor about getting a simple blood sugar test to confirm it. Then, if you’re diagnosed with prediabetes, consider joining a lifestyle change program offered by the Natio...
The CDC webpage "Types of Insulin" provides an overview of the various insulin types used in diabetes management, categorized by their onset, peak time, and duration of action. It explains terms lik...
Manual:
Know How to Use Your Asthma Inhaler.
Using a metered dose inhaler (inhaler in mouth).
The trematodes Fasciola hepatica (also known as the common liver fluke or the sheep liver fluke) and Fasciola gigantica are large liver flukes (F. hepatica: up to 30 mm by 15 mm; F. gigantica: up to 75 mm by 15 mm), which are primarily found in dome...
Information for the General Public
Information for the General Public
Let's Stop HIV together
Accessed: 19.10.2019
Let's Stop HIV together
Accessed: 19.10.2019
The Alere Filariaisis Test Strip (FTS) is a diagnostic test used to detect filarial antigens for lymphatic filariasis. This training video was developed by ENVISION in collaboration with the US Centers fo... Disease Control and Prevention, with funding provided by the US Agency for International Development.
It provides selected illustrations and photographs of congenital anomalies that are severe enough to have a high probability of being captured during the first few days following birth
The goal of this course is to provide participants with the foundational skills needed to begin the development, implementation and ongoing improvement of a congenital anomalies surveillance programme, in particular ... countries with limited resources. It focuses on the methodology needed to develop either population-based or hospital based surveillance programmes.
A set of congenital anomalies will be used as examples throughout this course. The specific examples used are typically severe enough that they would probably be captured within the first few days after birth, have a significant public health impact and, for some of them, have the potential for primary prevention.
The Africa Centres for Disease Control and Preventio... (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity systems and enabling them to comply with national and international requirements for biosafety and biosecurity including the International Health Regulations (IHR) (2005), the Biological Weapons Convention (BWC), and United Nations Security Council Resolution (UNSCR) 1540 and the multi-country Global Health Security Agenda (GHSA). The World Health Organization (WHO) Joint External Evaluation (JEE) and the Global Health Security Index report confirmed the known capacity gaps in biosafety and biosecurity among Africa Union Member (AU).
The regional consultations by Africa CDC conducted between 2019-2021 highlighted the deficiency or limited availability of standardized and regionally recognized training programs in the continent, limiting biosafety and biosecurity capacity building efforts in the region. In response, Africa CDC working with AU Member States developed a home grown, implementable and accessible professional training and certification program that is both recognized and endorsed by AU Member States. The Regional Training and Certification Program for Biosafety and Biosecurity Professionals, for African Biosafety and Biosecurity Professionals (RTCP-BBP) has four (4) areas of specialization, namely
Selection, Installation, Maintenance and Certification of Biological Safety Cabinets
Biorisk Management
Design and Maintenance of Facilities Handling High Risk Pathogens (Biocontainment Engineering)
Biological Waste management
The Africa Centres for Disease Control and Preventio... (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity systems and enabling them to comply with national and international requirements for biosafety and biosecurity including the International Health Regulations (IHR) (2005), the Biological Weapons Convention (BWC), and United Nations Security Council Resolution (UNSCR) 1540 and the multi-country Global Health Security Agenda (GHSA). The World Health Organization (WHO) Joint External Evaluation (JEE) and the Global Health Security Index report confirmed the known capacity gaps in biosafety and biosecurity among Africa Union Member (AU).
The regional consultations by Africa CDC conducted between 2019-2021 highlighted the deficiency or limited availability of standardized and regionally recognized training programs in the continent, limiting biosafety and biosecurity capacity building efforts in the region. In response, Africa CDC working with AU Member States developed a home grown, implementable and accessible professional training and certification program that is both recognized and endorsed by AU Member States. The Regional Training and Certification Program for Biosafety and Biosecurity Professionals, for African Biosafety and Biosecurity Professionals (RTCP-BBP) has four (4) areas of specialization, namely
- Selection, Installation, Maintenance and Certification of Biological Safety Cabinets
- Biorisk Management
- Design and Maintenance of Facilities Handling High Risk Pathogens (Biocontainment Engineering)
- Biological Waste management
On 13 August 2024, Africa Centres for Disease Control and ... (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public health emergency of international concern (PHEIC). After these declarations, many countries have made efforts to mobilize resources to introduce or expand laboratory testing, surveillance, and response activities. In particular, as the number of suspected cases surges in the Democratic Republic of Congo (DRC), Burundi, and the Central African Republic, and an increasing number of new countries report cases, there is an urgent need to implement testing to strengthen the Mpox response. However, access to appropriate quality assured diagnostics is a challenge. There is limited information on important characteristics, such as available test kits’ performance and ability to detect relevant clades.
To address the challenge of mpox access in the continent, the Africa CDC Diagnostic Advisory Committee (DAC) met in Kigali from 19-23 August 2024 to review the available evidence on molecular tests for Mpox and to shortlist tests that may be useful for Mpox testing in countries. The shortlist aims to provide guidance to Africa CDC, countries and partners on appropriate high-quality molecular tests to procure and use for the mpox response.
The importance of robust mortality surveillance systems cannot be overstated in an era marked by increasing global health challenges where health threats loom large and population dynamics continue to evolve. Accurate ... timely mortality data is essential for identifying trends and detecting emerging health threats, evaluating the impact of interventions, and guiding evidence-based policy decisions.
This framework outlines a holistic approach to strengthening routine mortality surveillance systems, considering the unique contextual factors and challenges faced by African countries. It emphasizes the importance of establishing efficient data collection mechanisms, enhancing data quality and completeness, and promoting data sharing and collaboration among stakeholders.
Moreover, the framework recognizes the pivotal role of technology in the integration of data from fragmented mortality data sources. It highlights the potential of innovative data capture methods, advanced analytics, and real-time reporting systems to enhance mortality data’s accuracy, efficiency, and timeliness.
The continental framework for mortality surveillance aligns with Africa CDC’s mission and strategic goal by serving as a fundamental component in strengthening public health systems, enhancing disease surveillance capacities and capabilities, informing evidence-based policies and interventions, and promoting collaboration and coordination among African countries to address health challenges and improve health outcomes on the continent.
The successful implementation of this framework requires collective commitment and concerted efforts from governments, health institutions, and the international community. We hope this document will serve as a catalyst for transformative change, enabling countries to build resilient mortality surveillance systems that protect public health, save lives, and contribute to evidence-based decision-making.
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like ... occurred in monkeys kept for research. The first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
